Does RISANKIZUMAB-RZAA Cause Paralysis? 20 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Paralysis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
20
Reports of Paralysis with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
9
Hospitalizations
How Dangerous Is Paralysis From RISANKIZUMAB-RZAA?
Of the 20 reports, 9 (45.0%) required hospitalization.
Is Paralysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Paralysis?
ADALIMUMAB (275)
INTERFERON BETA-1A (181)
METHOTREXATE (181)
PREGABALIN (171)
RITUXIMAB (166)
ATORVASTATIN (160)
DIMETHYL (156)
FINGOLIMOD (145)
NATALIZUMAB (136)
ETANERCEPT (134)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Paralysis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA